Réforme du système de fixation des prix et évolution du marché privé des médicaments au Maroc

OBJECTIVE: The study shows the evolution of the market for medicines sold in pharmacies following the price revisions published by the Ministry of Health after the reform of the pricing system adopted in December 2013. METHODS: This is a retrospective study carried out following the crossing of lists of official price review bulletins published on the website of the General Secretariat of the Government and sales data for medicines between 2010 and 2018. RESULTS: Between 2010 and 2018, the total private market for generic and originator medicines recorded an average annual growth of +3% in volume and +3.7% in turnover. Between 2015 and 2018 and after the implementation of the reform, it rose from +1.1% to +3.9%. Once the price revisions were applied, the sales volume of generic medicines recorded an average annual growth of +3.5%, compared to +5.1% for their turnover (2015 and 2018). However, the sales volume of originator medicines recorded negative average annual growth (-0.7%). As for the segment of medicines affected by price reductions, between 2015 and 2018 it experienced negative average annual growth in volume (-0.8%), while its growth in turnover was positive (+3.3%). CONCLUSION: Following the adoption of the terms of Decree 2-13-852 and the application of the revisions, the private medicines market has seen variable growth.